1. Home
  2. ANVS vs KNDI Comparison

ANVS vs KNDI Comparison

Compare ANVS & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • KNDI
  • Stock Information
  • Founded
  • ANVS 2008
  • KNDI 2002
  • Country
  • ANVS United States
  • KNDI China
  • Employees
  • ANVS N/A
  • KNDI N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • ANVS Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • ANVS 92.6M
  • KNDI 91.2M
  • IPO Year
  • ANVS 2020
  • KNDI N/A
  • Fundamental
  • Price
  • ANVS $2.72
  • KNDI $1.10
  • Analyst Decision
  • ANVS Strong Buy
  • KNDI
  • Analyst Count
  • ANVS 6
  • KNDI 0
  • Target Price
  • ANVS $31.40
  • KNDI N/A
  • AVG Volume (30 Days)
  • ANVS 571.1K
  • KNDI 118.9K
  • Earning Date
  • ANVS 03-31-2025
  • KNDI 03-13-2025
  • Dividend Yield
  • ANVS N/A
  • KNDI N/A
  • EPS Growth
  • ANVS N/A
  • KNDI N/A
  • EPS
  • ANVS N/A
  • KNDI N/A
  • Revenue
  • ANVS N/A
  • KNDI $118,127,232.00
  • Revenue This Year
  • ANVS N/A
  • KNDI N/A
  • Revenue Next Year
  • ANVS N/A
  • KNDI N/A
  • P/E Ratio
  • ANVS N/A
  • KNDI N/A
  • Revenue Growth
  • ANVS N/A
  • KNDI N/A
  • 52 Week Low
  • ANVS $2.59
  • KNDI $0.89
  • 52 Week High
  • ANVS $20.00
  • KNDI $2.98
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 18.19
  • KNDI 50.35
  • Support Level
  • ANVS $2.99
  • KNDI $1.03
  • Resistance Level
  • ANVS $5.50
  • KNDI $1.12
  • Average True Range (ATR)
  • ANVS 0.33
  • KNDI 0.06
  • MACD
  • ANVS -0.19
  • KNDI -0.01
  • Stochastic Oscillator
  • ANVS 4.30
  • KNDI 26.92

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

Share on Social Networks: